3Semana·

$UNH (-0,62 %) 's long-term EPS growth target of 13-16% is achievable, supported by the company's strong track record.


The stock looks reasonably priced right now, especially given the company's reliability and steady growth over the years.

attachment
8
1 Comentario

Whats your though on Elevance Healthcare $ELV at current price?
Únase a la conversación